Proust François, Debono Bertrand, Hannequin Didier, Gerardin Emmanuel, Clavier Erick, Langlois Olivier, Fréger Pierre
Department of Neurosurgery, Rouen University Hospital, Rouen, France.
J Neurosurg. 2003 Jul;99(1):3-14. doi: 10.3171/jns.2003.99.1.0003.
Endovascular and surgical treatment must be clearly defined in the management of anterior communicating artery (ACoA) aneurysms. In this study the authors report their recent experience in using a combined surgical and endovascular team approach for ACoA aneurysms, and compare these results with those obtained during an earlier period in which surgical treatment was used alone. Morbidity and mortality rates, causes of unfavorable outcomes, and morphological results were also assessed.
The prospective study included 223 patients who were divided into three groups: Group A (83 microsurgically treated patients, 1990-1995); Group B (103 microsurgically treated patients, 1996-2000); and Group C (37 patients treated with Guglielmi Detachable Coil [GDC] embolization, 1996-2000). Depending on the direction in which the aneurysm fundus projected, the authors attempted to apply microsurgical treatment to Type 1 aneurysms (located in front of the axis formed by the pericallosal arteries). They proposed the most adapted procedure for Type 2 aneurysms (located behind the axis of the pericallosal arteries) after discussion with the neurovascular team, depending on the physiological status of the patient, the treatment risk, and the size of the aneurysm neck. In accordance with the classification of Hunt and Hess, the authors designated those patients with unruptured aneurysms (Grade 0) and some patients with ruptured aneurysms (Grades I-III) as having good preoperative grades. Patients with Grade IV or V hemorrhages were designated as having poor preoperative grades. By performing routine angiography and computerized tomography scanning, the causes of unfavorable outcome (Glasgow Outcome Scale [GOS] score < 5) and the morphological results (complete or incomplete occlusion) were analyzed. Overall, the clinical outcome was excellent (GOS Score 5) in 65% of patients, good (GOS Score 4) in 9.4%, fair (GOS Score 3) in 11.6%, poor (GOS Score 2) in 3.6%, and fatal in 10.3% (GOS Score 1). Among 166 patients in good preoperative grades, an excellent outcome was observed in 134 patients (80.7%). The combined permanent morbidity and mortality rate accounted for up to 19.3% of patients. The rates of permanent morbidity and death that were related to the initial subarachnoid hemorrhage were 6.2 and 1.5% for Group A, 6.6 and 1.3% for Group B, and 4 and 4% for Group C, respectively. The rates of permanent morbidity and death that were related to the procedure were 15.4 and 1.5% for Group A, 3.9 and 0% for Group B, and 8 and 8% for Group C, respectively. When microsurgical periods were compared, the rate of permanent morbidity or death related to microsurgical complications decreased significantly (Group A, 11 patients [16.9%] and Group B, three patients [3.9%]); Fisher exact test, p = 0.011) from the period of 1990 to 1995 to the period of 1996 to 2000. The combined rate of morbidity and mortality that was related to the endovascular procedure (16%) explained the nonsignificance of the different rates of procedural complications for the two periods, despite the significant decrease in the number of microsurgical complications. Among 57 patients in poor preoperative grade, an excellent outcome was observed in 11 patients (19.3%); however, permanent morbidity (GOS Scores 2-4) or death (GOS Score 1) occurred in 46 patients (80.7%). With regard to the correlation between vessel occlusion (the primary microsurgical complication) and the morphological characteristics of aneurysms, only the direction in which the fundus projected appeared significant as a risk factor for the microsurgically treated groups (Fisher exact test: Group A, p = 0.03; Group B, p = 0.002). The difference between endovascular and microsurgical procedures in the achievement of complete occlusion was considered significant (chi2 = 6.13, p = 0.01).
The direction in which the fundus projects was chosen as the morphological criterion between endovascular and surgical methods. The authors propose that microsurgical clip application should be the preferred option in the treatment of ACoA aneurysms with anteriorly directed fundi and that endovascular packing be selected for those lesions with posteriorly directed fundi, depending on morphological criteria.
在前交通动脉(ACoA)动脉瘤的治疗中,血管内治疗和外科治疗必须有明确的界定。在本研究中,作者报告了他们近期采用外科和血管内联合团队方法治疗ACoA动脉瘤的经验,并将这些结果与早期单纯采用外科治疗时获得的结果进行比较。还评估了发病率、死亡率、不良结局的原因以及形态学结果。
这项前瞻性研究纳入了223例患者,分为三组:A组(83例接受显微外科治疗的患者,1990 - 1995年);B组(103例接受显微外科治疗的患者,1996 - 2000年);C组(37例接受 Guglielmi 可脱性弹簧圈[GDC]栓塞治疗的患者,1996 - 2000年)。根据动脉瘤瘤底的投影方向,作者试图对1型动脉瘤(位于胼周动脉形成的轴线前方)采用显微外科治疗。对于2型动脉瘤(位于胼周动脉轴线后方),作者在与神经血管团队讨论后,根据患者的生理状态、治疗风险和动脉瘤颈的大小,提出最适合的手术方法。根据Hunt和Hess分级,作者将未破裂动脉瘤患者(0级)和部分破裂动脉瘤患者(I - III级)指定为术前分级良好。IV级或V级出血患者被指定为术前分级差。通过进行常规血管造影和计算机断层扫描,分析不良结局(格拉斯哥结局量表[GOS]评分<5)的原因和形态学结果(完全或不完全闭塞)。总体而言,65%的患者临床结局为优(GOS评分5),9.4%为良(GOS评分4),11.6%为中(GOS评分3),3.6%为差(GOS评分2),10.3%为死亡(GOS评分1)。在166例术前分级良好的患者中,134例(80.7%)观察到优的结局。永久性合并发病率和死亡率占患者总数的19.3%。与初始蛛网膜下腔出血相关的永久性发病率和死亡率在A组分别为6.2%和1.5%,B组分别为6.6%和1.3%,C组分别为4%和4%。与手术相关的永久性发病率和死亡率在A组分别为15.4%和1.5%,B组分别为3.9%和0%,C组分别为8%和8%。当比较显微外科手术时期时,与显微外科并发症相关的永久性发病率或死亡率从1990年至1995年到1996年至2000年显著降低(A组,11例患者[16.9%];B组,3例患者[3.9%];Fisher精确检验,p = 0.011)。尽管显微外科并发症数量显著减少,但与血管内手术相关的合并发病率和死亡率(16%)解释了两个时期手术并发症不同发生率无显著差异的原因。在57例术前分级差的患者中,11例(19.3%)观察到优的结局;然而,46例(80.7%)发生了永久性合并症(GOS评分2 - 4)或死亡(GOS评分1)。关于血管闭塞(主要的显微外科并发症)与动脉瘤形态学特征之间的相关性,仅瘤底的投影方向作为显微外科治疗组的危险因素具有显著意义(Fisher精确检验:A组,p = 0.03;B组,p = 0.002)。血管内手术和显微外科手术在实现完全闭塞方面的差异被认为具有显著性(χ² = 6.13,p = 0.01)。
瘤底的投影方向被选为血管内和外科方法之间的形态学标准。作者建议,对于瘤底向前的ACoA动脉瘤,显微外科夹闭应作为首选治疗方法;对于瘤底向后的病变,根据形态学标准应选择血管内填塞。